If you're attending the @MassBio Align Summit 2026, catch Matthew Baker's presentation and let's talk about finding Stage I-II cancers, when outcomes for patients can really improve.
#MassBio #AlignSummit26 #EarlyDetection #Cancer
#WHIS2026 is starting tomorrow! We're looking forward to connecting with investors and partners across #WomenHealth.
Reach out if you are interested in working with us to make #EarlierDetection of #GynecologicCancers accessible to more women.
#Innovation #CancerDiagnostics
Be sure to catch Prof. Paul Brennan today as he pitches and stands at Dxcover's Poster #130, highlighting our work in #BrainCancer #EarlyDetection.
Attending the conference? Stop by and let us know what you think. Leave a comment below or tag us in your posts. #CancerResearch
We're looking forward to the #EarlyDetectionOfCancer Conference in #Edinburgh, #Scotland, next week. As a Glasgow-based company, it's fantastic to have a global gathering of experts in early cancer detection just a short train journey away. #ContactUs #CancerDiagnostics
Treatment for #gynecologic cancers is more effective at early stages. As we recently discussed here: lnkd.in/eWtnWM86
Today marks the end of #GynaecologicalCancerAwarenessMonth, but not our commitment to a future where #EarlyDetection gives women #MoreTime.
#Innovation
Dxcover’s Head of Product & Business Development, Alisa Tubbs, will be attending the Women’s Health Innovation Summit 2026 in Boston next month.
Get in touch with us to schedule a meeting!
#WHIS2026 #WomenHealth #Innovation #Networking #GynecologicCancers
TechTour Mental & Brain Health 2026 kicks off tomorrow!
Don’t miss Dxcover’s CEO, Matthew Baker, pitching at Session V on Friday.
DM us to schedule a meeting.
#TechTour #BrainHealth #Networking #HealthTech #LiquidBiopsy
Dxcover’s CEO will be attending Tech Tour Mental & Brain Health 2026 in Glasgow next week.
We are looking forward to connecting with investors and innovators to exchange ideas and build new relationships!
#TechTour #BrainHealth #Networking #HealthTech #Innovation
September is #GynecologicalCancerAwarenessMonth and we highlight the importance of developing new approaches to #EarlyDetection.
#OvarianCancer remains one of the most challenging cancers to identify early, yet Dxcover's blood-based platform showed 93% sensitivity in stage I!
Don’t miss the latest article from Dxcover’s General Manager on how our Dxcover Brain test has approached regulatory submission: linkedin.com/pulse/innovatio…
#Dxcover #Brain #Innovation #Regulation
Great to see medical applications represented in AI scale-ups.
#Dxcover #AI #MedTech #Innovation
theaiinsider.tech/2026/07/23…
Focusing on solutions on #WorldLungCancerDay🫁💡The #Dxcover blood-based testing platform presents a quick turnaround test that is highly sensitive at all stages, supporting screening & improving compliance. Together we can detect cancer earlier and see better patients outcomes!
Abigail is joining the All Party Parliamentary Group (#appg) for a session on #LessSurvivableCancers.
The @LessSurvivable focuses on patients affected by cancers of the brain, liver, lungs, pancreas, oesophagus, and stomach and advocates for action to improve survival rates.
#UterineCancer is the most common #Gynecologic cancer in the US and UK, and the n. of cases is expected to increase by 50% by 2045*
June is #UterineCancerAwarenessMonth, a timely reminder of raising awareness to support earlier diagnosis and improve outcomes.
*IARC & #IGCS
#UCAM



















